Daunorubicin hydrochloride CAS: 23541-50-6

Daunorubicin hydrochloride ni umuti ukomeye wa chimiotherapie ukoreshwa mu kuvura kanseri zitandukanye, harimo kanseri y’imitsi ikaze (AML), kanseri y’imitsi ikaze (ALL), na kanseri itari iya Hodgkin. Ikoreshwa kandi mu kuvura ubwoko bumwe na bumwe bw’ibibyimba bikomeye nka sarcomas na kanseri y’ibere. Uyu muti ukunze gutangwa mu mitsi mu bitaro cyangwa mu ivuriro uyobowe n’inzobere mu by’ubuzima zifite uburambe mu gutanga imiti ya chimiotherapie. Igipimo n’uburyo bwo kuvura bigenwa hashingiwe ku bintu nk’ubwoko n’urwego rwa kanseri, ubuzima bw’umurwayi muri rusange, n’ubuvuzi bwabanje kuvurwa. Abarwayi bavurwa na daunorubicin hydrochloride bashobora kugira ingaruka mbi nko kugira isesemi, kuruka, gutakaza umusatsi, no kwiyongera kwandura indwara bitewe no kugabanuka k’umubare w’uturemangingo tw’amaraso tw’umweru. Gukurikirana buri gihe umubare w’amaraso n’imikorere y’umutima ni ngombwa mu gihe cyo kuvurwa kugira ngo bigabanye uburozi bushobora guterwa n’uyu muti. Ni ngombwa ko abarwayi bakurikiza amabwiriza y’umuganga neza, bakitabira gahunda zagenwe, kandi bagatanga raporo ku bimenyetso byose bijyanye nawo vuba. Kurangiza imiti yose ya chimiotherapie nk’uko byategetswe ni ingenzi kugira ngo inyungu zishobora guterwa no kuvurwa na daunorubicin hydrochloride. Muri make, daunorubicin hydrochloride igira uruhare runini mu kuvura kanseri zitandukanye, iha abaganga b’inzobere mu kuvura kanseri igikoresho cy’ingenzi mu kurwanya indwara mbi hibandwa ku turemangingo twa kanseri no kubangamira ubushobozi bwazo bwo kwiyongera no gukwirakwira.